Dr. Narkhede is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1720 2nd Avenue South
NP2540F North Pavilion
Birmingham, AL 35294Phone+1 205-934-2248Fax+1 949-698-6272
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2016- Cleveland Clinic FoundationInternship, Internal Medicine, 2013 - 2014
KJ Somaiya Medical CollegeClass of 2006
Certifications & Licensure
AL State Medical License 2019 - 2024
DC State Medical License 2016 - 2020
OH State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy Start of enrollment: 2021 Nov 15
Roles: Principal Investigator, Contact
- Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia Start of enrollment: 2023 Dec 18
Roles: Sponsor-Investigator, Principal Investigator, Contact
- PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL Start of enrollment: 2024 Jun 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 14 citationsEvaluating real-world treatment patterns and outcomes of mantle cell lymphoma.Mayur Narkhede, Gaurav Goyal, Lauren Shea, Amit Mehta, Smith Giri
Blood Advances. 2022-07-26 - 48 citationsPrimary effusion lymphoma: current perspectives.Mayur Narkhede, Shagun Arora, Chaitra S. Ujjani
Oncotargets and Therapy. 2018-06-28 - 2 citationsModern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in...Gaurav Goyal, Tylan Magnusson, Xiaoliang Wang, James Roose, Mayur Narkhede
Haematologica. 2023-04-01
Lectures
- External Validation and Revision of Thrombosis Lymphoma /Throly/ Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
